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Abstract 
Purpose: The National Committee for Quality Assurance (NCQA) has standards for recognizing Patient-Centered Medical Homes 
(PCMH) including one for medication management. Study objectives were to identify if and how providers within a PCMH recognized 
under the 2008 guidelines were documenting components of medication management to meet NCQA’s 2011 requirements including: 
1) providing information about new prescriptions to >80% of patients; 2) assessing understanding of medications for >50% of 
patients; and 3) assessing response and barriers to medication adherence for >50% of patients.  
Methods: Physician and pharmacist-led patient visits from a family medicine office, from February 1 to August 1, 2012 were 
assessed. Patients over 18 years old taking at least one medication were included. A retrospective chart review was performed to 
assess documented components of medication management. Descriptive statistics were used to analyze data.  
Results: A systematic sampling of 450 physician-led and 195 pharmacist-led patient visits, demonstrated providers did not meet 
documentation goals for providing patients information on new prescriptions (65% pharmacist, 24% physician, 36% of total provider 
notes) or for assessment of patients’ understanding of medications (9% pharmacist 12% physician, 11% of total provider notes). 
Individually each type of provider did not meet the goal of assessing patient response and barriers to adherence to medication, but 
with combined intervention by the pharmacists and the physicians, the site was able to surpass NCQA’s percentage goal (57% and 
58%).  
Conclusions: No components of medication management are well documented. Using the electronic medical record, pharmacists 
may be able to develop documentation tools and assist sites to meet NCQA’s goals for medication management.  
 
 
Introduction 
With healthcare reform legislation, patient-centered medical 
homes (PCMH) are considered be the future of primary care 
in the United States.1-2 PCMHs facilitate collaboration among 
health professionals to provide team-based, coordinated care 
with a focus on chronic disease state management and 
preventive care.2-4 Introduced by the American Academy of 
Pediatrics (AAP) in 1967, PCMHs have evolved through 
collaboration with AAP, the American Academy of Family 
Physicians (AAFP), the American College of Physicians (ACP), 
and the American Osteopathic Association (AOA) and has 
resulted in the development of the joint definition of PCMH 
by these organizations.5-6  As healthcare continues to evolve 
in the United States, the number of PCMHs are likely to grow  
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and the need to standardize qualifications to become a PCMH 
will become increasingly important.  
 
There are multiple organizations that accredit or recognize 
PCMHs including The Joint Commission (TJC), the 
Accreditation Association for Ambulatory Health Care 
(AAAHC), and the National Committee for Quality Assurance 
(NCQA).  NCQA standards are used most often to distinguish 
sites as PCMHs. As of October 2014, there were over 8,300 
NCQA recognized PCMHs in the US.3 There are six 2011 NCQA 
standards used to evaluate PCMHs and these standards are 
further divided into elements and factors used to assess the 
sites. (Table 1) The levels of PCMH recognition include basic 
(tier 1), intermediate (tier 2), or advanced (tier 3), and sites 
are awarded a tier based on the number of points 
accumulated by fulfilling components of each standard.3, 7 
Sites are reevaluated every three years and those that are 
recognized as advanced or tier 3 PCMHs may receive the 
highest levels of reimbursement from insurance companies.3,8 
To be evaluated for PCMH recognition, NCQA will review 
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providers’ documentation of patient care visits and activities 
to assess completion of the standards. There is no literature 
that discusses if and how providers are documenting to meet 
NCQA PCMH standards. 
 
Pharmacists can be integral members of the interdisciplinary 
PCMH team, and they continue to expand their role in direct 
patient care services by performing chronic disease state 
management, medication therapy management, medication 
reconciliation, and assistance with transitions of care.2,4,6,8,10-
11  There is little literature discussing how pharmacists can 
assist their site in meeting the NCQA PCMH standards. In a 
white paper created by the Pennsylvania Pharmacists 
Association, Berdine et al. states that pharmacists are in the 
position to help with the accreditation of their sites and 
provide collaborative drug therapy management within a 
PCMH.8 A review done by Abrons and Smith, suggests that 
pharmacists should help their sites by focusing on sections of 
the PCMH standards related to “medication workflow, 
processes, and quality measures.” 2 The section of the 2011 
NCQA PCMH standards directly related to medications is 
Standard 3D, medication management. Pharmacists may 
have a significant role in helping provide and document 
patient care activities to meet Standard 3D, as pharmacists 
are the most qualified healthcare professional to assess all 
components of medication management. (Table 2) When this 
project was completed, it was based on existing 2011 NCQA 
PCMH guidelines.  These guidelines were updated in 2014 
after completion of this project.  The 2014 guidelines, the 
third edition of the PCMH standards, reorganized previous 
versions to focus on team-based care. Despite updates in the 
PCMH guidelines, components of medication management 
and the role for pharmacists to participate in this element has 
not changed.  
 
At the time of this project, our site was converting from the 
2008 standards to the 2011 NCQA standards. We saw that as 
an opportunity for pharmacists to assist since the 2008 NCQA 
standards did not require sites to meet medication 
management metrics as compared to 2011 standards.  The 
2011 standard for medication management required sites at 
a minimum to meet the critical factor of reviewing and 
reconciling medications for more than fifty percent of care 
transitions or during fifty percent of patient visits.3, The focus 
of this study was to evaluate if and how providers, including 
pharmacists and physicians working as a team under the 
2008 guidelines, document NCQA’s updated 2011 standard 
3D medication management beyond medication 
reconciliation including: 1) Providing information to patients 
about new prescriptions to >80% of patients, 2) assessing 
patient understanding of medications for >50% of patients, 
and 3) assessing patient response and barriers to adherence 
to medications for >50% of patients.  
 
Table 1 
NCQA’s Standards for Patient 
Centered Medical Home 20117 
NCQA’s Standards for Patient 
Centered Medical Home 201415 
1. Enhance Assess and Continuity 1. Patient-Centered Access 
2. Identify and Manage Patient 
Populations 
2. Team-Based Care 
3. Plan and Manage Care 3. Population Health Management  
A. Implement Evidence-
Based Guidelines 
4. Care Management and Support 
B. Identify High-Risk Patients A. Identify Patients for Care 
Management  
C. Care Management B. Care Planning and Self-Care 
Support 
D. Medication Management* C. Medication Management* 
E. Use Electronic Prescribing D. Use Electronic Prescribing 
4. Provide Self-Care Support and 
Community Resources 
E. Support Self-Care and 
Shared Decision Making 
5. Track and Coordinate Care 5. Care Coordination & Care 
Transitions 
6. Measure and Improve 
Performance 
6. Performance Measurement and 
Quality Improvement  
*Focus of this study 
 
Table 2 
2011 NCQA Standard: 3D: Medication Management9  
and 2014 NCQA Standard 4C: Medication Management15 
Factors:  
1. Reviews and reconciles medications for more than 50% of care 
transitions-CRITICAL FACTOR  
2. Reviews and reconciles medications for more than 80% of care 
transitions 
3. Provides information about new prescriptions to more than 
80% of patients* 
4. Assess patient understanding of medications for more than 
50% of patients* 
5. Assesses patient response to medication and barriers to 
adherence for more than 50% of patients* 
6. Documents OTCs, herbal/supplements, for more than 50% of 
patients, with date of update 
 
Critical factor: must be met by PCMHs to receive any points 
for this standard  
*Focus for this study 
 
Methods 
Setting 
Exempt status for this study was granted by The Ohio State 
University Institutional Review Board. This study evaluated a 
large primary care/family medicine office that is one of eight 
PCMHs within a large academic medical center. This site was 
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recognized as a 2008 NCQA tier 3 PCMH and at the time of 
this study was preparing for re-accreditation under the 2011 
NCQA standards. The interdisciplinary team is comprised of 
ten family medicine physicians, three College of Pharmacy 
faculty pharmacists that are employed for 0.4 full time 
equivalents (FTEs), one PGY-1 pharmacy resident that spends 
approximately 0.3 FTE at the site, twenty-one medical 
assistants, a part-time dietician, a nurse practitioner 
specializing in mental health, and a part-time social worker. 
At this location, pharmacists provide services including 
chronic disease state management with a primary focus on 
diabetes, hypertension, and hyperlipidemia, perform 
comprehensive medication reviews, and answer drug 
information questions from the staff.  
Data Collection  
The electronic medical record (EMR) was used to generate a 
report of patients who were between the ages of 18-89 years 
and had a visit with a family medicine physician or pharmacist 
during February 1, 2012 to August 1, 2012. Patients not 
taking medications were excluded from the study. All 
pharmacist-led patient visit notes and a systematic sample of 
physician-led patient visit notes were included. Due to the 
consistent documentation of each physician, we only 
evaluated 50 care visits from each of the physicians. A total of 
nine physicians x 50 visits each = 450 total visits analyzed. 
For the selected patient visits, a retrospective chart review 
was performed to identify if providers documented 
completion of the NCQA’s components of medication 
management beyond medication reconciliation using the 
NCQA’s 2011 PCMH evaluation document. (Table 2) These 
2011 medication management components are the same in 
the updated 2014 NCQA standards. To assess if physicians 
and pharmacists provided information or counseled patients 
on new prescriptions, each patient visit note was reviewed to 
see if a new medication(s) was prescribed during the visit. If a 
new medication was added that day, the note was reviewed 
to see if the provider documented that they gave information 
or counseled the patient about the new prescription. Each 
patient visit note was also reviewed to see if the provider 
documented the patient’s understanding of his/her 
medications, if the patient had problems or difficulty taking 
their medications, and assessed adherence to medications 
and barriers to adherence. NCQA does not specify how 
providers should document these items, which allows each 
provider the freedom to document in a variety of methods. 
Examples of how providers documented each  of these 
components were recorded along with the total number of 
patient visits conducted by providers during the inclusion 
period and are described in the results. 12 
Results 
From February 1, 2012 to August 1, 2012, there were a total 
of 11,932 patient visits for nine family medicine physicians, 
three pharmacists, and one pharmacy practice resident at the 
practice site. One family medicine physician changed practice 
locations during this time period, and those patients were 
excluded from the analysis. Of those total patient visits, 
11,737 or 98.4% were physician-led visits and 195 or 1.6% 
were pharmacist-led visits. After the systematic sampling, 450 
of the physician-led visits were analyzed along all the 
pharmacist-led visits in the retrospective chart review. The 
data was evaluated from December 2012 until February 
2013. The providers documented the components of 
medication management using a variety of methods. 
Percentage of providers that documented components of 
medication management are shown in Figures 1, 2, and 3.  
Figure 1 depicts the incidence of documentation within the 
patient note related provision of information to patients on 
new prescriptions. The total providers’ documentation of this 
factor did not meet 2011 NCQA’s percentage goal of at or 
greater than 80%, but this documentation occurred more 
often in pharmacist-led visits versus physician-led visits (65% 
vs 24%). To account for documentation of this factor, the 
provider must have included that they counseled the patient, 
reviewed the medication, or informed the patient of what to 
expect from the new medication including side effects, risk 
and benefit of the medication, or any medication precautions 
or warnings. Simply mentioning the new medication in the 
electronic medical record including the instructions for use 
was not accepted as adequate documentation to meet this 
factor. Examples of provider documentation accepted to 
meet this factor included: treatment risk and benefits of 
medication discussed, side effect profile and precautions 
discussed with patient, medication use if applicable has been 
reviewed, discussed medication and potential side effects, 
provided counseling on [name of medication]. 
Figure 2 illustrates documentation of the assessment of 
patients’ understanding of their medication(s). The total 
providers’ documentation of this factor did not meet the 
2011 NCQA’s percentage goal of at or greater than 50%, but 
this documentation occurred more often in physician-led 
visits versus pharmacist-led visits (12% vs 9%). To account for 
the documentation of this factor, the provider must have 
documented that they asked the patient if they understood 
the medication’s directions or instructions for use or 
answered questions about the medication to the patient’s 
satisfaction. Examples of provider documentation accepted 
to meet this factor included: patient verbalized 
understanding of [medication name] instructions, patient 
voices understanding of [medication name] directions, and 
answered medication questions to patient’s satisfaction. 
Figure 3a displays the incidence of documentation related to 
assessment of patients’ response to medication(s). 
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Documentation of this medication management component 
occurred more often in pharmacist-led visits versus physician-
led visits. (77% vs. 49%)  To account for the documentation of 
this factor, the provider must have documented that they 
asked the patient if they were able to tolerate or had side 
effects to their medication(s).  Examples of provider 
documentation accepted to meet study objective 3a 
included: patient tolerates medications, patient compliant 
without side effects, no new side effects, patient currently 
experiencing the following side effects [side effects], and 
patient has/had [signs/symptoms] reaction to medications.  
Figure 3b highlights documentation related to assessment of 
patients’ adherence and barriers to adherence. To account 
for the documentation of this factor, the provider must have 
documented if they asked the patient if he or she missed any 
doses of medication, was adherent or compliant to the 
medication regimen, or reasons for non-adherence. 
Documentation of this medication management component 
occurred more often in pharmacist-led visits versus physician-
led visits. (96% vs. 42%) Examples of provider documentation 
to meet study objective 3b included: no missed medications, 
patient adherence [number of days] out of the week, 
compliance with medication regimen [number of days] out of 
the week, non-adherence discussed, patient non-adherence 
due to [insert reason for non-adherence], and barriers to 
adherence addressed. 
Discussion  
The results of this study showed that neither group of 
providers met the 2011 NCQA’s percentage goals for 
documentation of components of medication management 
related to providing information to patients about new 
prescriptions and assessing patients’ understanding of 
medications. Except for the documentation of assessing 
patients’ understanding of medication, pharmacists 
documented components of medication management more 
often than physicians.  In assessing and documenting the 
patient’s response to medications and barriers to adherence, 
physicians did not meet the 2011 NCQA’s documentation 
percentage goal of at or greater than 50% of patient visits, 
but together physicians and pharmacists surpassed 2011 
NCQA’s percentage goal. (57% and 58%)  
The site’s lower percentages for the completion of these 
components could be contributed to provider under-
documentation, lack of time to document after patient 
encounters, and providers still utilizing the 2008 NCQA 
guidelines for documentation during the transition to 2011 
requirements. Providers in this setting may have assessed 
components of medication management but might not have 
documented completion of these activities in their patients’ 
notes. Providers also may not have been aware of the 
changes between the 2008 and 2011 standards.  The 2011 
version had percentage goals for the components of 
medication management and providers maybe unfamiliar 
with these requirements for documentation and evaluation 
of these standards.   
There are several limitations to this study that relate to the 
general limitations of using the EMR to document and 
evaluate patient visits. 13, 14 In analyzing documentation of 
thirteen different providers, a challenge in data collection 
was sifting through all the information and interpreting how 
each of these providers documented completion of 
medication management. Many of the providers had their 
own individualized style when it came to documentation of 
their patient encounters. Within the EMR, all of the 
physicians had different documentation templates to record 
patient encounter notes while the pharmacists used the same 
templates.  Some of the providers incorporated the 
assessment of medication management into their 
documentation template, so providers were prompted to 
assess and document Standard 3D in all of their patients’ 
visits. To decrease variations in interpreting providers’ 
documentation, analysis of patient charts was conducted by 
one pharmacist.  
During the course of this study, the pharmacists were invited 
to be a part of the steering committee responsible for the re-
evaluation of the eight PCMH sites within the academic 
medical center for reaccreditation under the 2011 standards.  
The PCMH site has made many quality improvements related 
to medication management including the incorporation of 
Standard 3D into all of the providers’ documentation 
templates in preparation for re-accreditation based on the 
2011 guidelines. These improvements have made it easier for 
each patient to be assessed for this standard at each visit.  
The pharmacists within the network have also developed 
documentation shortcuts for commonly prescribed 
medications that can be used by any provider within the 
academic medical center. These shortcuts include basic 
counseling points for medications, such as, directions for use, 
common side effects, and warnings and precautions that can 
be quickly incorporated into the patient’s after visit summary 
(AVS). The AVS is printed and given to each patient before 
they leave the PCMH office, and it can help providers meet 
the requirements of counseling patients on new medications. 
Providers have also begun to document patient self-
management of disease states to help assess the 
effectiveness of medication, as well as the patients’ use of 
OTC medications. 
This is the first study to evaluate if and how providers are 
documenting to meet 2011 NCQA PCMH Standard 3D, 
medication management.  Despite an update to the NCQA 
PCHM guidelines after the completion of this project, 
medication management and all of the components remain a 
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part of the 2014 guidelines. The new guidelines have 
reorganized and renamed each standard, and only change 
regarding this element is its placement in the guidelines. 
Medication management has moved from Standard 3, 
Element D in the 2008 and 2011 NCQA guidelines to Standard 
4, Element C in the 2014 version.15 (Table 1)  
This study emphasizes the importance of documenting 
patient care activities not only for continuity of patient care 
and for liability purposes but also for NCQA PCMH evaluation.  
Medication reconciliation and medication management 
continue to be an important part of the NCQA PCMH 
standards and even though they may be performed by any 
members of the PCMH team, pharmacists are specifically 
trained to perform these activities.  Pharmacists can also get 
involved with PCMHs by becoming a part of a steering 
committee that is responsible for NCQA evaluation and 
develop tools or resources to make medication management 
a routine part of patient care at their site.   
The results of this study will aid the site and other PCMHs in 
the network to efficiently and effectively document 
medication management, as well as increase pharmacists’ 
involvement in the PCMH evaluation process for the 
upcoming reaccreditation. Future studies in this area could 
evaluate if and how providers are documenting other NCQA 
standards and how pharmacists are involved in helping their 
sites meet other standards.  Other studies could also evaluate 
how different sites and other medical centers document 
patient care activities using the EMR. As the number of PCMH 
sites continues to grow in the US, sites must be able to 
provide adequate documentation of all patient care activities 
to submit to NCQA for evaluation. Pharmacists may have a 
role in not only providing documentation of their activities 
but could also work with other providers to streamline the 
documentation process and help their site gain PCMH 
recognition.  
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